{"gene":"NANOG","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2007,"finding":"Nanog is dispensable for somatic pluripotency maintenance but specifically required for primordial germ cell maturation upon reaching the genital ridge; Nanog-null PGCs fail to mature, and this defect is rescued by repair of the mutant allele.","method":"Genetic deletion (Nanog knockout) with chimera analysis and germline rescue experiments in mouse","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with allelic rescue, replicated across multiple experimental contexts in one rigorous study","pmids":["18097409"],"is_preprint":false},{"year":2008,"finding":"NANOG homodimerizes through its C-terminal domain (not the homeodomain), and this dimerization is required for interaction with other pluripotency network proteins and for functional LIF-independent self-renewal of ES cells.","method":"Co-immunoprecipitation, domain deletion mapping, enforced expression of monomer vs. dimer constructs with functional self-renewal assay in mouse ES cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP with domain mapping and functional rescue, single lab with multiple orthogonal methods","pmids":["18436640"],"is_preprint":false},{"year":2006,"finding":"NANOG physically interacts with SALL4 in mouse ES cells; both proteins co-occupy Nanog and Sall4 enhancer regions, and knockdown of either factor reduces enhancer activity, indicating they form a positive regulatory circuit.","method":"Affinity purification coupled to LC-MS/MS, Co-IP, GST pulldown, ChIP, RNAi knockdown with reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP confirmed by GST pulldown plus ChIP co-occupancy and functional reporter assays in one study","pmids":["16840789"],"is_preprint":false},{"year":2013,"finding":"NANOG physically associates with TET1 and TET2 in mouse ES cells; TET1 is recruited by NANOG to co-occupied genomic loci (including Esrrb and Oct4), and TET1 binding is reduced upon NANOG depletion. NANOG–TET1/TET2 interaction enhances reprogramming in a manner dependent on TET catalytic activity, increasing 5-hydroxymethylcytosine at target loci.","method":"Enhanced affinity purification/MS to identify NANOG interactors, Co-IP confirmation, ChIP-seq co-occupancy, TET1 catalytic mutant, 5hmC measurement, knockdown of TET2 in reprogramming assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (MS, Co-IP, ChIP-seq, catalytic mutant, 5hmC quantification) in single rigorous study","pmids":["23395962"],"is_preprint":false},{"year":2014,"finding":"ERK1 binds and phosphorylates NANOG; MEK/ERK-mediated phosphorylation decreases NANOG protein stability through ubiquitination-mediated proteasomal degradation, and induces binding of E3 ubiquitin ligase FBXW8 to NANOG, promoting its degradation and triggering ES cell differentiation.","method":"In vitro kinase assay, Co-IP, ubiquitination assay, MEK inhibitor treatment, overexpression/knockdown in mouse ES cells with self-renewal readout","journal":"Stem cell research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase assay plus Co-IP plus ubiquitination assay and functional ES cell readout, single lab","pmids":["24793005"],"is_preprint":false},{"year":2018,"finding":"SPOP promotes NANOG poly-ubiquitination and proteasomal degradation via a conserved degron motif on NANOG; cancer-associated SPOP mutations or Nanog-degron mutation (S68Y) disrupt this interaction and stabilize NANOG. Pin1 oncoprotein impairs NANOG recognition by SPOP, stabilizing NANOG, and Pin1 inhibitors promote SPOP-mediated NANOG destruction.","method":"Co-IP, ubiquitination assay, domain/degron mutation analysis, Pin1 interaction assay, in vivo tumor models","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent labs (PMIDs 30595535 and 30595538) with Co-IP, ubiquitination assays, and mutant analysis converge on same mechanism","pmids":["30595538","30595535"],"is_preprint":false},{"year":2018,"finding":"AMPK-BRAF signaling phosphorylates NANOG at Ser68, which blocks the interaction between SPOP and NANOG, thereby preventing SPOP-mediated NANOG degradation and elevating prostate cancer stemness.","method":"Phosphorylation mapping, Co-IP with SPOP-NANOG interaction assay, S68Y mutation, AMPK/BRAF manipulation in prostate cancer cells","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — phosphorylation site identified and confirmed by mutant disrupting SPOP-NANOG interaction, multiple orthogonal methods in one study","pmids":["30595535"],"is_preprint":false},{"year":2016,"finding":"USP21 deubiquitylase interacts with NANOG via its C-terminal USP domain binding to the C-domain of NANOG; USP21 removes K48-linked polyubiquitin chains from NANOG, stabilizing it. Depletion of USP21 in mouse ES cells leads to NANOG degradation and differentiation.","method":"Co-IP in vivo and in vitro, domain deletion mapping, deubiquitylation assay (K48 linkage), USP21 knockdown in mouse ES cells with NANOG protein level and pluripotency readout","journal":"Signal transduction and targeted therapy","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro deubiquitylation assay with domain mapping, Co-IP, and functional KD readout, single lab multiple orthogonal methods","pmids":["29263902"],"is_preprint":false},{"year":2013,"finding":"Phosphorylation of human NANOG by protein kinase Cε at T200 and T280 enhances NANOG protein stability; phosphorylation-insensitive mutants (T200A, T280A) have dominant-negative function, impairing NANOG homodimerization, DNA binding, promoter occupancy, and p300 co-activator recruitment, thereby abrogating Bmi1 transactivation. Bmi1 is identified as a critical downstream target of NANOG in tumorigenesis.","method":"Kinase assay with PKCε, phosphorylation-insensitive and phosphomimetic mutants, Co-IP for homodimerization, ChIP for DNA binding and p300 recruitment, luciferase reporter, in vivo xenograft tumor initiation assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — kinase assay plus multiple mutant readouts (dimerization, ChIP, reporter, in vivo), single lab","pmids":["23708658"],"is_preprint":false},{"year":2014,"finding":"Endogenous human NANOG is phosphorylated at 11 sites; ERK2 and CDK1/CyclinA2 directly phosphorylate NANOG at specific residues identified by the MAKS (multiplexed assay for kinase specificity) approach.","method":"Mass spectrometry of endogenous NANOG phosphopeptides, MAKS in vitro kinase specificity assay with site-specific identification","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with direct phosphosite mapping by MS, novel multiplexed platform, single lab","pmids":["24678451"],"is_preprint":false},{"year":2008,"finding":"Med12 physically interacts with NANOG in mouse ES cells; Med12 and NANOG co-occupy Nanog target promoters; Med12 knockdown phenocopies Nanog knockdown with increased expression of Nanog-repressed targets and decreased expression of Nanog-activated targets.","method":"Co-IP, ChIP, RNAi knockdown with gene expression profiling in mouse ES cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ChIP co-occupancy plus functional knockdown, single lab","pmids":["19036726"],"is_preprint":false},{"year":2009,"finding":"KLF4 directly binds the proximal NANOG promoter and PBX1 binds a new upstream enhancer and proximal promoter of NANOG in human ES cells; both factors co-operate with OCT4 and SOX2 to synergistically transactivate NANOG expression, and their knockdown or mutation of binding motifs reduces NANOG promoter activity.","method":"NANOG promoter luciferase reporter, ChIP, EMSA, overexpression/knockdown, mutagenesis of binding motifs in human ES cells","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP and EMSA confirming direct binding plus functional mutagenesis and KD, multiple orthogonal methods single lab","pmids":["19522013"],"is_preprint":false},{"year":2009,"finding":"NANOG and CDX2 bind to and directly repress each other's promoters; NANOG overexpression suppresses trophectoderm markers, while NANOG knockdown upregulates TE markers.","method":"ChIP, promoter reporter assay, conditional TE differentiation ES cell line, NANOG overexpression and knockdown","journal":"Cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct binding plus functional gain/loss-of-function, single lab","pmids":["19564890"],"is_preprint":false},{"year":2007,"finding":"NANOG directly binds the proximal promoter of Gata6 and represses its expression; NANOG overexpression reduces heterogeneity and Gata6-high cell frequency in mouse ES cells.","method":"ChIP at Gata6 proximal promoter, NANOG overexpression with quantitative marker analysis in mouse ES cells","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional overexpression readout, single lab","pmids":["17615266"],"is_preprint":false},{"year":2022,"finding":"Human NANOG contains a C-terminal prion-like domain that phase-transitions to gel-like condensates; full-length NANOG forms higher-order oligomers at low nanomolar concentrations. NANOG oligomerization is essential for bridging DNA elements in vitro, and prion-like domain assembly is required for specific DNA recognition and distant chromatin interactions in cells, providing a physical basis for chromatin reorganization and dose-sensitive activation of ground-state pluripotency.","method":"Single-molecule FRET, fluorescence cross-correlation spectroscopy, phase-transition assays, ChIP-seq, Hi-C 3.0 in cells, prion-like domain mutants","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution (smFRET, FCS, in vitro DNA bridging) combined with in-cell ChIP-seq and Hi-C with domain mutants, multiple orthogonal Tier 1-2 methods in one study","pmids":["35484250"],"is_preprint":false},{"year":2022,"finding":"In zebrafish embryos, Nanog clusters prior to transcription body formation; Nanog clustering is required for subsequent Sox19b clustering and transcription initiation. Both the DNA-binding domain and an intrinsically disordered region of Nanog are required to organize transcription bodies.","method":"Live imaging of fluorescent reporters in zebrafish embryos, mutant analysis of Nanog domains (DNA-binding domain and IDR), transcription body formation assay","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live-cell imaging with genetic domain mutants in zebrafish, single lab","pmids":["36476751"],"is_preprint":false},{"year":2019,"finding":"Zebrafish Nanog and Pou5f3 bind to high nucleosome affinity regions (HNARs) at zygotic genome activation; in the first step, Pou5f3 and Nanog destabilize nucleosomes at HNAR centers before ZGA; in the second step, Nanog, Pou5f3, and SoxB1 synergistically maintain open chromatin—Nanog binds to HNAR center while Pou5f3 stabilizes flanks.","method":"MNase-seq in wild-type and maternal-zygotic pou5f3 and nanog mutant zebrafish embryos, computational nucleosome occupancy modeling","journal":"Genome research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MNase-seq with genetic mutants in zebrafish, single lab","pmids":["30674556"],"is_preprint":false},{"year":2010,"finding":"Medaka Nanog (Ol-Nanog) is expressed in PGCs and directly regulates Cxcr4b transcription by binding its promoter; Nanog depletion causes aberrant PGC migration and loss of Cxcr4b expression; simultaneous overexpression of Cxcr4b rescues the migration defect caused by Nanog depletion.","method":"ChIP (Ol-Nanog binding to Cxcr4b promoter), morpholino knockdown of Ol-Nanog, Cxcr4b mRNA rescue experiment in medaka","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP confirming direct binding plus genetic rescue experiment, multiple orthogonal methods single lab","pmids":["20578184"],"is_preprint":false},{"year":2018,"finding":"In zebrafish maternal-zygotic nanog mutants, YSL formation and epiboly fail; Nanog is required for yolk microtubule organization, miR-430-mediated maternal mRNA degradation, and actin structure of the yolk syncytial layer. Cell death in MZnanog embryos is cell-autonomous. Nanog regulates spatial expression of ventral-specifying genes (bmp2b, vox, vent), neural factor her3, and degradation of maternal eomesa mRNA.","method":"Maternal-zygotic nanog mutant zebrafish analysis, chimera rescue experiments, live imaging, in situ hybridization, actin and microtubule staining","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cellular readouts in genetic null mutants with chimeric rescue, single lab","pmids":["29180568"],"is_preprint":false},{"year":2016,"finding":"NANOG directly occupies the p27KIP1 (CDKN1B) promoter and represses its transcription; Nanog transduction into primary fibroblasts suppresses senescence-associated β-galactosidase activity and downregulates p27KIP1, correlating with enhanced proliferation.","method":"ChIP confirming Nanog binding at p27KIP1 gene; cell-permeant Nanog-TAT protein transduction; proliferation and senescence assays in NIH 3T3 and primary fibroblasts","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for direct binding plus functional protein transduction readout, single lab","pmids":["26795560"],"is_preprint":false},{"year":2015,"finding":"DPPA5 directly interacts with NANOG protein in human PSCs, stabilizes NANOG via a post-transcriptional mechanism, and enhances NANOG function; DPPA5 overexpression increases NANOG protein levels without affecting mRNA, and DPPA5 depletion reduces NANOG.","method":"Co-immunoprecipitation, protein stability assay, quantitative RT-PCR (confirming post-transcriptional effect), overexpression/knockdown in human PSCs","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus protein stability assay plus mRNA vs protein dissociation, single lab","pmids":["26661329"],"is_preprint":false},{"year":2012,"finding":"SUMOylation of Oct4 enhances NANOG expression, while SUMOylation of Sox2 inhibits NANOG expression. Depletion of Sumo1 or its conjugating enzyme Ubc9 increases Nanog expression; high SUMOylation reduces it. SUMOylation of Oct4 by Pias2 or Sox2 by Pias3 impairs the Oct4–Sox2 interaction.","method":"SUMOylation assays, Sumo1/Ubc9 knockdown, Pias2/Pias3 overexpression, Co-IP for Oct4-Sox2 interaction, NANOG expression readout in ES cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical SUMOylation assays plus Co-IP plus functional gene expression readout, single lab","pmids":["22745796"],"is_preprint":false},{"year":2019,"finding":"NANOG directly binds the upstream region of ICAM1 in prostate cancer cells; as NANOG binding increases, p300 binding to this region is diminished, resulting in decreased ICAM1 expression, enabling cancer cells to evade NK cell attack.","method":"ChIP-seq (NANOG and p300), RNAseq, generation of NANOG-overexpressing/knockout transformants, NK cell cytotoxicity assays, xenograft in SCID mice","journal":"Journal of experimental & clinical cancer research : CR","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq for NANOG and p300 co-occupancy plus functional NK resistance assay, single lab","pmids":["31619256"],"is_preprint":false},{"year":2022,"finding":"GATA6 and NANOG co-bind at the vast majority of epiblast and primitive endoderm enhancers, including in blastocysts. Upon GATA6 induction, co-bound state resolves by NANOG eviction and repression of epiblast TFs, with rapid chromatin remodeling and enhancer-promoter contact changes establishing primitive endoderm lineage.","method":"ChIP-seq for GATA6 and NANOG in ES cells and blastocysts, GATA6 induction system, chromatin accessibility assays, Hi-C/enhancer-promoter contact mapping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq replicated in two systems (ES cells and blastocysts), chromatin dynamics with Hi-C, multiple orthogonal methods","pmids":["35871075"],"is_preprint":false},{"year":2018,"finding":"In bovine embryos, OCT4 is required for NANOG expression; OCT4 knockout blastocysts lack NANOG protein entirely in the ICM, while OCT4 is not required to suppress CDX2 in the ICM (contrasting with mouse).","method":"CRISPR-Cas9 OCT4 knockout in bovine fibroblasts, SCNT embryo production, immunofluorescence for NANOG, GATA6, CDX2 in blastocysts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR/KO with direct immunofluorescence protein readout in bovine blastocysts, single lab with rigorous controls","pmids":["29483258"],"is_preprint":false},{"year":2018,"finding":"Esrrb, a positively regulated direct NANOG target in ES cells, can functionally replace Nanog in PGC development in vivo; knockin of Esrrb at the Nanog locus restores PGC numbers to wild-type and yields fertile adults.","method":"Germline-specific Nanog deletion, PGCLC differentiation assay with Nanog-null ES cells, Esrrb knockin to Nanog locus, fertility assessment","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis by knockin rescue in two contexts (in vitro PGCLC and in vivo germline), replicated outcomes","pmids":["29320730"],"is_preprint":false},{"year":2014,"finding":"In mouse ES cells, Nanog-dependent feedback loops maintain ES cell population heterogeneity and fate decisions; early molecular changes after Nanog loss are stochastic and reversible, but prolonged Nanog absence consolidates commitment. Exogenous regulation of Nanog-dependent feedback control produces a more homogeneous ES cell population.","method":"Genetic complementation strategy, high-throughput single-cell transcriptional profiling, mathematical modeling, exogenous Nanog regulation","journal":"Nature cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-cell profiling with genetic manipulation and mathematical modeling, single lab","pmids":["23103910"],"is_preprint":false},{"year":2016,"finding":"YBX1 and ILF3 RNA-binding proteins interact with Nanog mRNA in mouse ES cells; knockdown of YBX1 or ILF3 reduces Nanog and other pluripotency gene expression and leads to mesoderm marker upregulation.","method":"Affinity purification of Nanog-interacting RBPs, RNA immunoprecipitation (RIP), immunofluorescence, FISH, MS2-BioTRAP, RNAi knockdown with gene expression readout","journal":"Cell biology international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP and MS2-BioTRAP confirming RNA interaction plus functional KD, single lab","pmids":["26289635"],"is_preprint":false},{"year":2023,"finding":"TRRAP directly binds NANOG (via TRRAP amino acids 1898–2400) and stabilizes NANOG protein by interfering with FBXW8-mediated ubiquitination; TRRAP depletion reduces cancer stem cell traits and tumor growth, which can be rescued by NANOG overexpression.","method":"Co-IP with TRRAP deletion mutants, ubiquitination assay, TRRAP knockdown/overexpression with NANOG protein stability readout, xenograft rescue experiment","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping, ubiquitination assay, functional rescue, single lab","pmids":["37047234"],"is_preprint":false},{"year":2014,"finding":"Nanog ChIP analysis showed physical binding to Cdx2 and Klf4 promoters in intestinal epithelium of Nanog-inducible mice, resulting in their downregulation, increased crypt cell proliferation, and intestinal hyperplasia without tumor formation.","method":"Tet-On inducible Nanog mouse model, ChIP at Cdx2 and Klf4 promoters, histological analysis of intestinal tissue","journal":"Stem cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP in vivo confirming direct promoter binding plus in vivo phenotypic readout, single lab","pmids":["25173648"],"is_preprint":false},{"year":2019,"finding":"NANOG and LIN28 drive reprogramming by activating LIN41 expression (a Let-7 miRNA target) and activating canonical WNT/β-CATENIN signaling; LIN41 can replace LIN28 synergizing with NANOG; dominant-negative LIN41 mutation blocks NANOG/LIN28-enhanced reprogramming.","method":"Reprogramming efficiency assays, pathway inhibitor treatments, dominant-negative LIN41 mutant, overexpression of LIN41 in OSKM context, measurement of WNT activation","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional epistasis via dominant-negative mutant and pathway inhibition, single lab","pmids":["31806618"],"is_preprint":false},{"year":2013,"finding":"In mouse ES cells, Satb1 and Satb2 both bind the Nanog locus in vivo; Satb1-deficient ES cells show increased Nanog expression and higher proportion of Nanog-high cells; Satb1 and Satb2 have antagonistic effects on Nanog expression and ES cell differentiation capacity.","method":"ChIP (Satb1 and Satb2 binding at Nanog locus), Satb1/Satb2 knockout ES cells, Satb2 overexpression, differentiation assays, cell fusion reprogramming assay","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at Nanog locus plus genetic KO readout, single lab","pmids":["19933152"],"is_preprint":false},{"year":2014,"finding":"BRD4 associates with BRG1 at Nanog regulatory regions in mouse ES cells to regulate Nanog expression; inhibition of BRD4 (chemically, siRNA, or dominant-negative) suppresses Nanog expression and abolishes ES cell self-renewal.","method":"ChIP (BRD4 and BRG1 at Nanog locus), BRD4 chemical inhibitor, siRNA knockdown, dominant-negative BRD4, Nanog expression and self-renewal readout","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus three independent BRD4 inhibition strategies, single lab","pmids":["25146928"],"is_preprint":false},{"year":2013,"finding":"CDX2 induction in mouse ES cells causes time-dependent increase in CDX2 binding and decrease in OCT4 binding at Nanog regulatory elements, loss of H3K9/14 acetylation and p300/HDAC1 binding, increased histone H3 occupancy, loss of chromatin accessibility, and only later DNA methylation at Nanog regulatory elements—demonstrating sequential epigenetic silencing of Nanog.","method":"Cdx2-inducible ES cell line, ChIP time course (CDX2, OCT4, RNAPII, H3K9/14ac, p300, HDAC1, total H3), chromatin accessibility assay, bisulfite sequencing","journal":"Stem cells and development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — detailed ChIP time course with multiple histone marks and TFs at Nanog locus, single lab","pmids":["24059348"],"is_preprint":false},{"year":2022,"finding":"NANOG triggers epiblast specification by ensuring coordinated expression of pluripotency markers; in Nanog/Gata6 double KO embryos, coordination of pluripotency markers fails, while individual marker expression remains variable in ICM progenitors.","method":"Nanog/Gata6 double knockout mouse embryo analysis, single-cell transcriptomics, immunofluorescence, analysis of human embryos","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with single-cell transcriptomics and cross-species validation, single lab","pmids":["35729116"],"is_preprint":false}],"current_model":"NANOG is a divergent homeodomain transcription factor that homodimerizes via its C-terminal domain—with dimerization required for interaction with pluripotency network partners and for LIF-independent self-renewal—forms higher-order prion-like oligomers through its C-terminal disordered domain to bridge distant chromatin elements and organize transcription bodies, directly occupies target gene promoters and enhancers (including Gata6, Cdx2, Cxcr4b, p27KIP1, Bmi1, ICAM1) to activate or repress transcription, interacts physically with TET1/TET2 to increase 5-hydroxymethylcytosine at pluripotency loci, with SALL4 and Med12 to co-regulate ES cell gene networks, and is itself subject to multilayered post-translational control: phosphorylation by ERK1/ERK2 and PKCε regulates its stability (via FBXW8-mediated K48-linked ubiquitination and proteasomal degradation), AMPK-BRAF-mediated phosphorylation at Ser68 modulates its recognition by the E3 ligase SPOP, and USP21 deubiquitylase and DPPA5/TRRAP stabilize NANOG protein, collectively controlling pluripotency maintenance, somatic reprogramming efficiency, germline development, and cancer stem cell traits."},"narrative":{"mechanistic_narrative":"NANOG is a divergent homeodomain transcription factor that operates at the core of the pluripotency network, directly occupying target promoters and enhancers to activate or repress lineage and self-renewal programs and to coordinate cell-fate decisions in the early embryo and germline [PMID:35871075, PMID:35729116, PMID:29320730]. It homodimerizes through its C-terminal domain rather than the homeodomain, and this dimerization is required both for assembly with pluripotency network partners and for LIF-independent self-renewal [PMID:18436640]; its C-terminal prion-like/intrinsically disordered region drives higher-order oligomerization and phase transition that bridges distant DNA elements, enables specific DNA recognition, and organizes transcription bodies for dose-sensitive activation of ground-state pluripotency [PMID:35484250, PMID:36476751]. NANOG nucleates an activating circuitry with SALL4 and the Mediator subunit Med12 to co-regulate ES cell gene networks [PMID:16840789, PMID:19036726], and recruits TET1/TET2 to co-bound loci to deposit 5-hydroxymethylcytosine and enhance reprogramming [PMID:23395962]. As a sequence-specific regulator it represses Gata6, Cdx2 and p27KIP1 and activates Esrrb and other targets, thereby suppressing endoderm/trophectoderm fate, controlling proliferation and senescence, and—through co-binding and resolution with GATA6—governing the epiblast versus primitive-endoderm decision [PMID:17615266, PMID:19564890, PMID:26795560, PMID:35871075]. In germ cells NANOG is specifically required for primordial germ cell maturation, a function that the direct target Esrrb can substitute for in vivo [PMID:18097409, PMID:29320730]. NANOG abundance is set by extensive post-translational control: ERK1/ERK2 and CDK1/CyclinA2 phosphorylate it, with ERK-driven phosphorylation triggering FBXW8-mediated K48-linked ubiquitination and degradation, while PKCε phosphorylation at T200/T280 stabilizes it and is required for dimerization, DNA binding and p300 recruitment to activate Bmi1 [PMID:24793005, PMID:24678451, PMID:23708658]. The E3 ligase SPOP targets a NANOG degron for degradation, an event blocked by AMPK-BRAF phosphorylation at Ser68 and by Pin1, whereas USP21 deubiquitylation and the DPPA5 and TRRAP stabilizers oppose turnover—a control axis that drives prostate cancer and cancer-stem-cell traits including immune evasion via ICAM1 repression [PMID:30595538, PMID:30595535, PMID:29263902, PMID:26661329, PMID:37047234, PMID:31619256]. Beyond pluripotency, NANOG governs nucleosome remodeling at zygotic genome activation and yolk syncytial layer/epiboly programs in fish embryos [PMID:30674556, PMID:29180568].","teleology":[{"year":2006,"claim":"Established that NANOG does not act alone but forms a positive autoregulatory circuit with a defined protein partner, framing it as a network hub rather than a solitary factor.","evidence":"Affinity-MS, reciprocal Co-IP, GST pulldown, ChIP co-occupancy and reporter assays in mouse ES cells defining the NANOG-SALL4 circuit","pmids":["16840789"],"confidence":"High","gaps":["Did not define which NANOG domain mediates SALL4 binding","Did not establish genome-wide scope of co-regulated targets"]},{"year":2007,"claim":"Resolved the apparent paradox of NANOG's role by showing it is dispensable for somatic pluripotency maintenance yet specifically essential for germ-cell maturation, defining a developmental-stage-specific requirement.","evidence":"Nanog knockout chimera analysis with allelic germline rescue in mouse; ChIP at the Gata6 promoter in a separate study","pmids":["18097409","17615266"],"confidence":"High","gaps":["Did not identify the germline target genes downstream of NANOG","Mechanism of stage specificity left open"]},{"year":2008,"claim":"Identified the structural basis of NANOG function by mapping C-terminal homodimerization and showing it is required for partner binding and self-renewal, and connected NANOG to the Mediator complex.","evidence":"Domain-deletion mapping with monomer/dimer constructs and self-renewal rescue; Co-IP/ChIP linking Med12 to NANOG targets in mouse ES cells","pmids":["18436640","19036726"],"confidence":"High","gaps":["Did not show the dimer structure at atomic resolution","Did not distinguish direct versus Mediator-bridged partner interactions"]},{"year":2009,"claim":"Defined the transcriptional inputs and reciprocal-repression logic governing NANOG, situating it in the OCT4/SOX2/KLF4/PBX1 activation circuit and the NANOG-CDX2 mutual antagonism that enforces lineage choice.","evidence":"Promoter reporter, ChIP, EMSA and motif mutagenesis in human ES cells; ChIP and gain/loss-of-function for NANOG-CDX2 mutual repression; ChIP at the Nanog locus for Satb1/Satb2","pmids":["19522013","19564890","19933152"],"confidence":"High","gaps":["Cross-species generality of these regulatory inputs not addressed","Did not quantify relative contribution of each upstream factor"]},{"year":2010,"claim":"Connected NANOG transcriptional output directly to germ-cell behavior by identifying a migration-guidance target gene whose re-expression rescues the loss-of-function phenotype.","evidence":"ChIP, morpholino knockdown and Cxcr4b mRNA rescue in medaka PGCs","pmids":["20578184"],"confidence":"High","gaps":["Whether vertebrate orthologs use the same NANOG-Cxcr4b axis untested","Did not address other migration regulators"]},{"year":2013,"claim":"Revealed two distinct mechanistic layers: NANOG recruits the DNA-demethylation machinery to remodel the epigenome, and PKCε phosphorylation stabilizes NANOG and licenses its DNA-binding/coactivator functions in tumorigenesis.","evidence":"Affinity-MS/Co-IP/ChIP-seq with TET1 catalytic mutant and 5hmC quantification; PKCε kinase assay with phospho-mutants, ChIP, reporter and xenograft assays","pmids":["23395962","23708658"],"confidence":"High","gaps":["Genome-wide rules for NANOG-directed TET recruitment incomplete","Functional weight of T200/T280 phosphorylation in normal pluripotency unresolved"]},{"year":2014,"claim":"Established that NANOG abundance is gated by kinase-coupled ubiquitination, with ERK/CDK1 phosphorylation feeding FBXW8-mediated proteasomal degradation that drives differentiation, and that population-level NANOG feedback governs cell-fate heterogeneity.","evidence":"In vitro kinase, Co-IP, ubiquitination and MEK-inhibitor assays in mouse ES cells; endogenous phosphosite MS with MAKS kinase-specificity mapping; single-cell profiling with genetic complementation; ChIP and BRD4/BRG1 inhibition at the Nanog locus; in vivo Cdx2/Klf4 promoter ChIP","pmids":["24793005","24678451","23103910","25146928","25173648"],"confidence":"High","gaps":["Hierarchy among the multiple phosphosites in vivo not resolved","Did not reconcile FBXW8 with later-identified SPOP-dependent degradation"]},{"year":2015,"claim":"Identified a post-transcriptional stabilizer of NANOG protein, expanding control of NANOG levels beyond transcription and kinase signaling.","evidence":"Co-IP, protein-stability and mRNA-versus-protein dissociation assays with DPPA5 in human PSCs","pmids":["26661329"],"confidence":"Medium","gaps":["Single lab without reciprocal in vivo validation","Did not define the DPPA5-NANOG interaction interface or the ligase it antagonizes"]},{"year":2016,"claim":"Showed that deubiquitylation actively opposes NANOG turnover and that NANOG transcriptionally represses a cell-cycle/senescence brake, linking its stability and target repression to proliferation control.","evidence":"Co-IP, domain mapping and K48 deubiquitylation assay with USP21 in mouse ES cells; ChIP at p27KIP1 with Nanog-TAT transduction and senescence assays; RIP/MS2-BioTRAP defining Nanog mRNA-binding proteins","pmids":["29263902","26795560","26289635"],"confidence":"High","gaps":["Whether USP21 and DPPA5/FBXW8 act on overlapping pools of NANOG unknown","Direct versus indirect p27KIP1 repression in vivo not fully resolved"]},{"year":2018,"claim":"Defined a clinically relevant degron-and-phosphorylation switch (SPOP/AMPK-BRAF-Ser68/Pin1) controlling NANOG stability in cancer, and refined the embryonic transcriptional hierarchy and germline target logic across species.","evidence":"Co-IP/ubiquitination/degron-mutant and Pin1 assays plus tumor models for SPOP and Ser68 (two independent labs); Esrrb knockin rescue of Nanog-null PGCs; CRISPR OCT4 knockout in bovine embryos; MZnanog zebrafish mutant analysis","pmids":["30595538","30595535","29320730","29483258","29180568"],"confidence":"High","gaps":["Interplay between SPOP and FBXW8 degradation pathways not directly compared","Species differences in the OCT4-NANOG-CDX2 hierarchy mechanistically unexplained"]},{"year":2019,"claim":"Linked NANOG to nucleosome destabilization at zygotic genome activation and to cancer immune evasion, broadening its mechanistic reach from pioneer-like chromatin opening to enhancer repression that lowers ICAM1 and NK susceptibility.","evidence":"MNase-seq in maternal-zygotic nanog/pou5f3 zebrafish mutants; ChIP-seq/RNA-seq with NANOG knockout and NK cytotoxicity/xenograft assays for ICAM1; reprogramming epistasis with LIN28/LIN41/WNT","pmids":["30674556","31619256","31806618"],"confidence":"Medium","gaps":["Whether NANOG acts as a bona fide pioneer factor or cooperates with co-factors at HNARs unresolved","Generality of ICAM1 repression beyond prostate cancer untested"]},{"year":2022,"claim":"Provided the biophysical basis for NANOG action by showing prion-like-domain-driven oligomerization and phase transition mediate DNA bridging, transcription-body organization, and dose-sensitive ground-state pluripotency, and detailed the GATA6 co-binding/eviction mechanism of lineage segregation.","evidence":"smFRET/FCS/phase-transition reconstitution with ChIP-seq and Hi-C 3.0 and prion-like-domain mutants; live imaging of Nanog/Sox19b clustering in zebrafish; GATA6/NANOG ChIP-seq with Hi-C in ES cells and blastocysts; Nanog/Gata6 double-KO single-cell embryo analysis","pmids":["35484250","36476751","35871075","35729116"],"confidence":"High","gaps":["In vivo dynamics and regulation of NANOG condensates incompletely defined","Mechanism coupling oligomerization state to target selectivity not fully resolved"]},{"year":2023,"claim":"Added a further stabilizing cofactor, showing TRRAP protects NANOG from FBXW8-mediated ubiquitination to sustain cancer-stem-cell traits, reinforcing degradation control as a therapeutic node.","evidence":"Co-IP with TRRAP deletion mutants, ubiquitination assay and xenograft rescue by NANOG overexpression","pmids":["37047234"],"confidence":"Medium","gaps":["Single lab; reciprocal in vivo validation limited","Whether TRRAP acts through its known complexes or independently to block FBXW8 unclear"]},{"year":null,"claim":"How the multiple, partly redundant degradation (FBXW8, SPOP) and stabilization (USP21, DPPA5, TRRAP, Pin1) inputs are integrated with phosphorylation and condensate state to set NANOG dosage in a given cell context remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model linking NANOG abundance, oligomerization and target selection","Relative dominance of competing E3 ligases and stabilizers across cell types unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,12,13,19,22,23,29]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[8,14,16]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,14]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,14,23]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[14,16]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,13,23,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,23,25,34]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,5,7,28]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[3,16,33]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,6,8,22]}],"complexes":[],"partners":["SALL4","TET1","TET2","MED12","SPOP","USP21","FBXW8","DPPA5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H9S0","full_name":"Homeobox protein NANOG","aliases":["Homeobox transcription factor Nanog","hNanog"],"length_aa":305,"mass_kda":34.6,"function":"Transcription regulator involved in inner cell mass and embryonic stem (ES) cells proliferation and self-renewal. Imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. Blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes. Acts as a transcriptional activator or repressor. Binds optimally to the DNA consensus sequence 5'-TAAT[GT][GT]-3' or 5'-[CG][GA][CG]C[GC]ATTAN[GC]-3'. Binds to the POU5F1/OCT4 promoter (PubMed:25825768). Able to autorepress its expression in differentiating (ES) cells: binds to its own promoter following interaction with ZNF281/ZFP281, leading to recruitment of the NuRD complex and subsequent repression of expression. When overexpressed, promotes cells to enter into S phase and proliferation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9H9S0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NANOG","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":380,"dependency_fraction":0.002631578947368421},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NANOG","total_profiled":1310},"omim":[{"mim_id":"621294","title":"ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 3; ZBTB3","url":"https://www.omim.org/entry/621294"},{"mim_id":"621222","title":"LINE1-TYPE TRANSPOSASE DOMAIN-CONTAINING PROTEIN 1; L1TD1","url":"https://www.omim.org/entry/621222"},{"mim_id":"621215","title":"NANOG HOMEOBOX RETROGENE P8; NANOGP8","url":"https://www.omim.org/entry/621215"},{"mim_id":"620692","title":"NANOG NEIGHBOR HOMEOBOX; NANOGNB","url":"https://www.omim.org/entry/620692"},{"mim_id":"620061","title":"CDK2-ASSOCIATED PROTEIN 2; CDK2AP2","url":"https://www.omim.org/entry/620061"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Not detected","tissue_distribution":"Not detected","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NANOG"},"hgnc":{"alias_symbol":["FLJ12581","FLJ40451"],"prev_symbol":[]},"alphafold":{"accession":"Q9H9S0","domains":[{"cath_id":"1.10.10.60","chopping":"105-154","consensus_level":"high","plddt":97.3368,"start":105,"end":154}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H9S0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H9S0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H9S0-F1-predicted_aligned_error_v6.png","plddt_mean":57.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NANOG","jax_strain_url":"https://www.jax.org/strain/search?query=NANOG"},"sequence":{"accession":"Q9H9S0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H9S0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H9S0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H9S0"}},"corpus_meta":[{"pmid":"18097409","id":"PMC_18097409","title":"Nanog safeguards pluripotency and mediates germline development.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/18097409","citation_count":1138,"is_preprint":false},{"pmid":"17211451","id":"PMC_17211451","title":"Nanog and transcriptional networks in embryonic stem cell pluripotency.","date":"2007","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17211451","citation_count":471,"is_preprint":false},{"pmid":"19582141","id":"PMC_19582141","title":"Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.","date":"2009","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/19582141","citation_count":423,"is_preprint":false},{"pmid":"23395962","id":"PMC_23395962","title":"NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23395962","citation_count":344,"is_preprint":false},{"pmid":"21499299","id":"PMC_21499299","title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21499299","citation_count":312,"is_preprint":false},{"pmid":"17615266","id":"PMC_17615266","title":"A heterogeneous expression pattern for Nanog in embryonic stem cells.","date":"2007","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/17615266","citation_count":284,"is_preprint":false},{"pmid":"16840789","id":"PMC_16840789","title":"Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16840789","citation_count":234,"is_preprint":false},{"pmid":"15939376","id":"PMC_15939376","title":"Nanog expression in mouse germ cell development.","date":"2005","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15939376","citation_count":219,"is_preprint":false},{"pmid":"23872274","id":"PMC_23872274","title":"Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells.","date":"2013","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/23872274","citation_count":139,"is_preprint":false},{"pmid":"21194951","id":"PMC_21194951","title":"Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions.","date":"2010","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/21194951","citation_count":137,"is_preprint":false},{"pmid":"19933152","id":"PMC_19933152","title":"Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression.","date":"2009","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/19933152","citation_count":116,"is_preprint":false},{"pmid":"23103910","id":"PMC_23103910","title":"Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity.","date":"2012","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23103910","citation_count":114,"is_preprint":false},{"pmid":"20173672","id":"PMC_20173672","title":"Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis.","date":"2010","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/20173672","citation_count":113,"is_preprint":false},{"pmid":"24375318","id":"PMC_24375318","title":"Emerging role of nanog in tumorigenesis and cancer stem cells.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24375318","citation_count":112,"is_preprint":false},{"pmid":"15233988","id":"PMC_15233988","title":"Eleven daughters of NANOG.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15233988","citation_count":112,"is_preprint":false},{"pmid":"19522013","id":"PMC_19522013","title":"KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.","date":"2009","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/19522013","citation_count":110,"is_preprint":false},{"pmid":"18436640","id":"PMC_18436640","title":"Requirement of Nanog dimerization for stem cell self-renewal and pluripotency.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18436640","citation_count":110,"is_preprint":false},{"pmid":"12787492","id":"PMC_12787492","title":"Nanog: a new recruit to the embryonic stem cell orchestra.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12787492","citation_count":105,"is_preprint":false},{"pmid":"19564890","id":"PMC_19564890","title":"Cross-regulation of the Nanog and Cdx2 promoters.","date":"2009","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19564890","citation_count":95,"is_preprint":false},{"pmid":"29483258","id":"PMC_29483258","title":"OCT4/POU5F1 is required for NANOG expression in bovine blastocysts.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29483258","citation_count":95,"is_preprint":false},{"pmid":"23653415","id":"PMC_23653415","title":"Concise review: pursuing self-renewal and pluripotency with the stem cell factor Nanog.","date":"2013","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/23653415","citation_count":92,"is_preprint":false},{"pmid":"35337852","id":"PMC_35337852","title":"Nanog, as a key cancer stem cell marker in tumor progression.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/35337852","citation_count":88,"is_preprint":false},{"pmid":"24793005","id":"PMC_24793005","title":"ERK1 phosphorylates Nanog to regulate protein stability and stem cell self-renewal.","date":"2014","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24793005","citation_count":88,"is_preprint":false},{"pmid":"26013997","id":"PMC_26013997","title":"Regulation of NANOG in cancer cells.","date":"2015","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26013997","citation_count":87,"is_preprint":false},{"pmid":"32428834","id":"PMC_32428834","title":"Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32428834","citation_count":84,"is_preprint":false},{"pmid":"26211876","id":"PMC_26211876","title":"Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.","date":"2015","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26211876","citation_count":78,"is_preprint":false},{"pmid":"30595535","id":"PMC_30595535","title":"AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.","date":"2018","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30595535","citation_count":76,"is_preprint":false},{"pmid":"33445692","id":"PMC_33445692","title":"Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33445692","citation_count":72,"is_preprint":false},{"pmid":"16540082","id":"PMC_16540082","title":"Nanog transforms NIH3T3 cells and targets cell-type restricted genes.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16540082","citation_count":65,"is_preprint":false},{"pmid":"30595538","id":"PMC_30595538","title":"SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.","date":"2018","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30595538","citation_count":63,"is_preprint":false},{"pmid":"25146928","id":"PMC_25146928","title":"BRD4 regulates Nanog expression in mouse embryonic stem cells and preimplantation embryos.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/25146928","citation_count":61,"is_preprint":false},{"pmid":"16259959","id":"PMC_16259959","title":"Expression of Nanog gene promotes NIH3T3 cell proliferation.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16259959","citation_count":59,"is_preprint":false},{"pmid":"21136380","id":"PMC_21136380","title":"Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.","date":"2010","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21136380","citation_count":59,"is_preprint":false},{"pmid":"21573506","id":"PMC_21573506","title":"Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells.","date":"2011","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21573506","citation_count":57,"is_preprint":false},{"pmid":"27877089","id":"PMC_27877089","title":"Insights into the Nanog gene: A propeller for stemness in primitive stem cells.","date":"2016","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27877089","citation_count":54,"is_preprint":false},{"pmid":"35177584","id":"PMC_35177584","title":"Nanog mediated by FAO/ACLY signaling induces cellular dormancy in colorectal cancer cells.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35177584","citation_count":54,"is_preprint":false},{"pmid":"19036726","id":"PMC_19036726","title":"Role for Med12 in regulation of Nanog and Nanog target genes.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19036726","citation_count":54,"is_preprint":false},{"pmid":"30674556","id":"PMC_30674556","title":"Pou5f3, SoxB1, and Nanog remodel chromatin on high nucleosome affinity regions at zygotic genome activation.","date":"2019","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/30674556","citation_count":54,"is_preprint":false},{"pmid":"32041418","id":"PMC_32041418","title":"NANOG expression in human development and cancerogenesis.","date":"2020","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/32041418","citation_count":53,"is_preprint":false},{"pmid":"32960465","id":"PMC_32960465","title":"The oncogenic potential of NANOG: An important cancer induction mediator.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32960465","citation_count":52,"is_preprint":false},{"pmid":"31891567","id":"PMC_31891567","title":"Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31891567","citation_count":50,"is_preprint":false},{"pmid":"20930529","id":"PMC_20930529","title":"NANOG promoter methylation and expression correlation during normal and malignant human germ cell development.","date":"2011","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20930529","citation_count":50,"is_preprint":false},{"pmid":"25284313","id":"PMC_25284313","title":"Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25284313","citation_count":50,"is_preprint":false},{"pmid":"22406932","id":"PMC_22406932","title":"Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.","date":"2012","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22406932","citation_count":47,"is_preprint":false},{"pmid":"31803983","id":"PMC_31803983","title":"NANOG is required to form the epiblast and maintain pluripotency in the bovine embryo.","date":"2019","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/31803983","citation_count":45,"is_preprint":false},{"pmid":"28240746","id":"PMC_28240746","title":"Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.","date":"2017","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28240746","citation_count":45,"is_preprint":false},{"pmid":"33468992","id":"PMC_33468992","title":"PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas.","date":"2021","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33468992","citation_count":43,"is_preprint":false},{"pmid":"16921504","id":"PMC_16921504","title":"Germ cell restricted expression of chick Nanog.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16921504","citation_count":43,"is_preprint":false},{"pmid":"29263902","id":"PMC_29263902","title":"USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency.","date":"2016","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29263902","citation_count":43,"is_preprint":false},{"pmid":"22745796","id":"PMC_22745796","title":"SUMOylation represses Nanog expression via modulating transcription factors Oct4 and Sox2.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22745796","citation_count":43,"is_preprint":false},{"pmid":"24678451","id":"PMC_24678451","title":"NANOG is multiply phosphorylated and directly modified by ERK2 and CDK1 in vitro.","date":"2014","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24678451","citation_count":43,"is_preprint":false},{"pmid":"16246159","id":"PMC_16246159","title":"The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells.","date":"2005","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/16246159","citation_count":42,"is_preprint":false},{"pmid":"35871075","id":"PMC_35871075","title":"Extensive co-binding and rapid redistribution of NANOG and GATA6 during emergence of divergent lineages.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35871075","citation_count":40,"is_preprint":false},{"pmid":"29320730","id":"PMC_29320730","title":"Esrrb Complementation Rescues Development of Nanog-Null Germ Cells.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29320730","citation_count":40,"is_preprint":false},{"pmid":"23708658","id":"PMC_23708658","title":"Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23708658","citation_count":40,"is_preprint":false},{"pmid":"23438436","id":"PMC_23438436","title":"LGR5 and Nanog identify stem cell signature of pancreas beta cells which initiate pancreatic cancer.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23438436","citation_count":38,"is_preprint":false},{"pmid":"21464727","id":"PMC_21464727","title":"Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma.","date":"2011","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/21464727","citation_count":37,"is_preprint":false},{"pmid":"35729116","id":"PMC_35729116","title":"NANOG initiates epiblast fate through the coordination of pluripotency genes expression.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35729116","citation_count":36,"is_preprint":false},{"pmid":"28378634","id":"PMC_28378634","title":"Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28378634","citation_count":34,"is_preprint":false},{"pmid":"30845764","id":"PMC_30845764","title":"Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30845764","citation_count":34,"is_preprint":false},{"pmid":"25339068","id":"PMC_25339068","title":"Slug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression.","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25339068","citation_count":32,"is_preprint":false},{"pmid":"35484250","id":"PMC_35484250","title":"NANOG prion-like assembly mediates DNA bridging to facilitate chromatin reorganization and activation of pluripotency.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35484250","citation_count":31,"is_preprint":false},{"pmid":"27884977","id":"PMC_27884977","title":"NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.","date":"2017","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/27884977","citation_count":30,"is_preprint":false},{"pmid":"29180568","id":"PMC_29180568","title":"Maternal Nanog is required for zebrafish embryo architecture and for cell viability during gastrulation.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29180568","citation_count":30,"is_preprint":false},{"pmid":"31806618","id":"PMC_31806618","title":"NANOG and LIN28 dramatically improve human cell reprogramming by modulating LIN41 and canonical WNT activities.","date":"2019","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/31806618","citation_count":30,"is_preprint":false},{"pmid":"24480805","id":"PMC_24480805","title":"Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis.","date":"2014","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24480805","citation_count":28,"is_preprint":false},{"pmid":"30657254","id":"PMC_30657254","title":"TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma.","date":"2019","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30657254","citation_count":28,"is_preprint":false},{"pmid":"31619256","id":"PMC_31619256","title":"NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31619256","citation_count":28,"is_preprint":false},{"pmid":"36476751","id":"PMC_36476751","title":"Nanog organizes transcription bodies.","date":"2022","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/36476751","citation_count":27,"is_preprint":false},{"pmid":"29486740","id":"PMC_29486740","title":"Nanog induced intermediate state in regulating stem cell differentiation and reprogramming.","date":"2018","source":"BMC systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/29486740","citation_count":27,"is_preprint":false},{"pmid":"29180571","id":"PMC_29180571","title":"The primary role of zebrafish nanog is in extra-embryonic tissue.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29180571","citation_count":27,"is_preprint":false},{"pmid":"20824089","id":"PMC_20824089","title":"NANOG reporter cell lines generated by gene targeting in human embryonic stem cells.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20824089","citation_count":25,"is_preprint":false},{"pmid":"20578184","id":"PMC_20578184","title":"Nanog regulates primordial germ cell migration through Cxcr4b.","date":"2010","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/20578184","citation_count":25,"is_preprint":false},{"pmid":"22934707","id":"PMC_22934707","title":"FAK and Nanog cross talk with p53 in cancer stem cells.","date":"2013","source":"Anti-cancer agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22934707","citation_count":25,"is_preprint":false},{"pmid":"26661329","id":"PMC_26661329","title":"DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/26661329","citation_count":24,"is_preprint":false},{"pmid":"29787607","id":"PMC_29787607","title":"Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29787607","citation_count":24,"is_preprint":false},{"pmid":"26795560","id":"PMC_26795560","title":"Nanog induces suppression of senescence through downregulation of p27KIP1 expression.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/26795560","citation_count":23,"is_preprint":false},{"pmid":"24465486","id":"PMC_24465486","title":"On the origin and evolutionary history of NANOG.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24465486","citation_count":22,"is_preprint":false},{"pmid":"19845468","id":"PMC_19845468","title":"PTEN and TRP53 independently suppress Nanog expression in spermatogonial stem cells.","date":"2010","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/19845468","citation_count":22,"is_preprint":false},{"pmid":"29779897","id":"PMC_29779897","title":"Inductive and Selective Effects of GSK3 and MEK Inhibition on Nanog Heterogeneity in Embryonic Stem Cells.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29779897","citation_count":22,"is_preprint":false},{"pmid":"33194046","id":"PMC_33194046","title":"LASP1 induces colorectal cancer proliferation and invasiveness through Hippo signaling and Nanog mediated EMT.","date":"2020","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/33194046","citation_count":22,"is_preprint":false},{"pmid":"37372456","id":"PMC_37372456","title":"Suppression of NANOG Expression Reduces Drug Resistance of Cancer Stem Cells in Glioblastoma.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37372456","citation_count":21,"is_preprint":false},{"pmid":"26289635","id":"PMC_26289635","title":"Nanog RNA-binding proteins YBX1 and ILF3 affect pluripotency of embryonic stem cells.","date":"2016","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/26289635","citation_count":21,"is_preprint":false},{"pmid":"32733958","id":"PMC_32733958","title":"Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma.","date":"2020","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/32733958","citation_count":20,"is_preprint":false},{"pmid":"24333425","id":"PMC_24333425","title":"Knockdown of p53 suppresses Nanog expression in embryonic stem cells.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24333425","citation_count":20,"is_preprint":false},{"pmid":"28977693","id":"PMC_28977693","title":"Nanog Expression in Embryonic Stem Cells - An Ideal Model System to Dissect Enhancer Function.","date":"2017","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28977693","citation_count":19,"is_preprint":false},{"pmid":"30092372","id":"PMC_30092372","title":"Functional characterization of NANOG in goat pre-implantation embryonic development.","date":"2018","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/30092372","citation_count":19,"is_preprint":false},{"pmid":"34693722","id":"PMC_34693722","title":"The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers.","date":"2021","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/34693722","citation_count":18,"is_preprint":false},{"pmid":"26939902","id":"PMC_26939902","title":"Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26939902","citation_count":18,"is_preprint":false},{"pmid":"28684962","id":"PMC_28684962","title":"Nanog Dynamics in Mouse Embryonic Stem Cells: Results from Systems Biology Approaches.","date":"2017","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/28684962","citation_count":18,"is_preprint":false},{"pmid":"25173648","id":"PMC_25173648","title":"Nanog induces hyperplasia without initiating tumors.","date":"2014","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/25173648","citation_count":17,"is_preprint":false},{"pmid":"30571656","id":"PMC_30571656","title":"MED20 is essential for early embryogenesis and regulates NANOG expression.","date":"2019","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30571656","citation_count":17,"is_preprint":false},{"pmid":"24681518","id":"PMC_24681518","title":"Cell-permeant recombinant Nanog protein promotes pluripotency by inhibiting endodermal specification.","date":"2014","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24681518","citation_count":17,"is_preprint":false},{"pmid":"31712708","id":"PMC_31712708","title":"FOXH1 Is Regulated by NANOG and LIN28 for Early-stage Reprogramming.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31712708","citation_count":16,"is_preprint":false},{"pmid":"33049683","id":"PMC_33049683","title":"Nanog promotes stem-like traits of glioblastoma cells.","date":"2021","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/33049683","citation_count":15,"is_preprint":false},{"pmid":"35733702","id":"PMC_35733702","title":"OCT4, SOX2 and NANOG co-regulate glycolysis and participate in somatic induced reprogramming.","date":"2022","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35733702","citation_count":15,"is_preprint":false},{"pmid":"37047234","id":"PMC_37047234","title":"TRRAP Enhances Cancer Stem Cell Characteristics by Regulating NANOG Protein Stability in Colon Cancer Cells.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37047234","citation_count":15,"is_preprint":false},{"pmid":"24059348","id":"PMC_24059348","title":"Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.","date":"2013","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/24059348","citation_count":15,"is_preprint":false},{"pmid":"34571882","id":"PMC_34571882","title":"Hypoblast Formation in Bovine Embryos Does Not Depend on NANOG.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34571882","citation_count":14,"is_preprint":false},{"pmid":"28601640","id":"PMC_28601640","title":"Functional evidence that the self-renewal gene NANOG regulates esophageal squamous cancer development.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28601640","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44412,"output_tokens":8450,"usd":0.129993,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18239,"output_tokens":5393,"usd":0.11301,"stage2_stop_reason":"end_turn"},"total_usd":0.243003,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Nanog is dispensable for somatic pluripotency maintenance but specifically required for primordial germ cell maturation upon reaching the genital ridge; Nanog-null PGCs fail to mature, and this defect is rescued by repair of the mutant allele.\",\n      \"method\": \"Genetic deletion (Nanog knockout) with chimera analysis and germline rescue experiments in mouse\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with allelic rescue, replicated across multiple experimental contexts in one rigorous study\",\n      \"pmids\": [\"18097409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NANOG homodimerizes through its C-terminal domain (not the homeodomain), and this dimerization is required for interaction with other pluripotency network proteins and for functional LIF-independent self-renewal of ES cells.\",\n      \"method\": \"Co-immunoprecipitation, domain deletion mapping, enforced expression of monomer vs. dimer constructs with functional self-renewal assay in mouse ES cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP with domain mapping and functional rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"18436640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NANOG physically interacts with SALL4 in mouse ES cells; both proteins co-occupy Nanog and Sall4 enhancer regions, and knockdown of either factor reduces enhancer activity, indicating they form a positive regulatory circuit.\",\n      \"method\": \"Affinity purification coupled to LC-MS/MS, Co-IP, GST pulldown, ChIP, RNAi knockdown with reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP confirmed by GST pulldown plus ChIP co-occupancy and functional reporter assays in one study\",\n      \"pmids\": [\"16840789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NANOG physically associates with TET1 and TET2 in mouse ES cells; TET1 is recruited by NANOG to co-occupied genomic loci (including Esrrb and Oct4), and TET1 binding is reduced upon NANOG depletion. NANOG–TET1/TET2 interaction enhances reprogramming in a manner dependent on TET catalytic activity, increasing 5-hydroxymethylcytosine at target loci.\",\n      \"method\": \"Enhanced affinity purification/MS to identify NANOG interactors, Co-IP confirmation, ChIP-seq co-occupancy, TET1 catalytic mutant, 5hmC measurement, knockdown of TET2 in reprogramming assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (MS, Co-IP, ChIP-seq, catalytic mutant, 5hmC quantification) in single rigorous study\",\n      \"pmids\": [\"23395962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ERK1 binds and phosphorylates NANOG; MEK/ERK-mediated phosphorylation decreases NANOG protein stability through ubiquitination-mediated proteasomal degradation, and induces binding of E3 ubiquitin ligase FBXW8 to NANOG, promoting its degradation and triggering ES cell differentiation.\",\n      \"method\": \"In vitro kinase assay, Co-IP, ubiquitination assay, MEK inhibitor treatment, overexpression/knockdown in mouse ES cells with self-renewal readout\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase assay plus Co-IP plus ubiquitination assay and functional ES cell readout, single lab\",\n      \"pmids\": [\"24793005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SPOP promotes NANOG poly-ubiquitination and proteasomal degradation via a conserved degron motif on NANOG; cancer-associated SPOP mutations or Nanog-degron mutation (S68Y) disrupt this interaction and stabilize NANOG. Pin1 oncoprotein impairs NANOG recognition by SPOP, stabilizing NANOG, and Pin1 inhibitors promote SPOP-mediated NANOG destruction.\",\n      \"method\": \"Co-IP, ubiquitination assay, domain/degron mutation analysis, Pin1 interaction assay, in vivo tumor models\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent labs (PMIDs 30595535 and 30595538) with Co-IP, ubiquitination assays, and mutant analysis converge on same mechanism\",\n      \"pmids\": [\"30595538\", \"30595535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AMPK-BRAF signaling phosphorylates NANOG at Ser68, which blocks the interaction between SPOP and NANOG, thereby preventing SPOP-mediated NANOG degradation and elevating prostate cancer stemness.\",\n      \"method\": \"Phosphorylation mapping, Co-IP with SPOP-NANOG interaction assay, S68Y mutation, AMPK/BRAF manipulation in prostate cancer cells\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation site identified and confirmed by mutant disrupting SPOP-NANOG interaction, multiple orthogonal methods in one study\",\n      \"pmids\": [\"30595535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"USP21 deubiquitylase interacts with NANOG via its C-terminal USP domain binding to the C-domain of NANOG; USP21 removes K48-linked polyubiquitin chains from NANOG, stabilizing it. Depletion of USP21 in mouse ES cells leads to NANOG degradation and differentiation.\",\n      \"method\": \"Co-IP in vivo and in vitro, domain deletion mapping, deubiquitylation assay (K48 linkage), USP21 knockdown in mouse ES cells with NANOG protein level and pluripotency readout\",\n      \"journal\": \"Signal transduction and targeted therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro deubiquitylation assay with domain mapping, Co-IP, and functional KD readout, single lab multiple orthogonal methods\",\n      \"pmids\": [\"29263902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Phosphorylation of human NANOG by protein kinase Cε at T200 and T280 enhances NANOG protein stability; phosphorylation-insensitive mutants (T200A, T280A) have dominant-negative function, impairing NANOG homodimerization, DNA binding, promoter occupancy, and p300 co-activator recruitment, thereby abrogating Bmi1 transactivation. Bmi1 is identified as a critical downstream target of NANOG in tumorigenesis.\",\n      \"method\": \"Kinase assay with PKCε, phosphorylation-insensitive and phosphomimetic mutants, Co-IP for homodimerization, ChIP for DNA binding and p300 recruitment, luciferase reporter, in vivo xenograft tumor initiation assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — kinase assay plus multiple mutant readouts (dimerization, ChIP, reporter, in vivo), single lab\",\n      \"pmids\": [\"23708658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Endogenous human NANOG is phosphorylated at 11 sites; ERK2 and CDK1/CyclinA2 directly phosphorylate NANOG at specific residues identified by the MAKS (multiplexed assay for kinase specificity) approach.\",\n      \"method\": \"Mass spectrometry of endogenous NANOG phosphopeptides, MAKS in vitro kinase specificity assay with site-specific identification\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with direct phosphosite mapping by MS, novel multiplexed platform, single lab\",\n      \"pmids\": [\"24678451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Med12 physically interacts with NANOG in mouse ES cells; Med12 and NANOG co-occupy Nanog target promoters; Med12 knockdown phenocopies Nanog knockdown with increased expression of Nanog-repressed targets and decreased expression of Nanog-activated targets.\",\n      \"method\": \"Co-IP, ChIP, RNAi knockdown with gene expression profiling in mouse ES cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ChIP co-occupancy plus functional knockdown, single lab\",\n      \"pmids\": [\"19036726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"KLF4 directly binds the proximal NANOG promoter and PBX1 binds a new upstream enhancer and proximal promoter of NANOG in human ES cells; both factors co-operate with OCT4 and SOX2 to synergistically transactivate NANOG expression, and their knockdown or mutation of binding motifs reduces NANOG promoter activity.\",\n      \"method\": \"NANOG promoter luciferase reporter, ChIP, EMSA, overexpression/knockdown, mutagenesis of binding motifs in human ES cells\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and EMSA confirming direct binding plus functional mutagenesis and KD, multiple orthogonal methods single lab\",\n      \"pmids\": [\"19522013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NANOG and CDX2 bind to and directly repress each other's promoters; NANOG overexpression suppresses trophectoderm markers, while NANOG knockdown upregulates TE markers.\",\n      \"method\": \"ChIP, promoter reporter assay, conditional TE differentiation ES cell line, NANOG overexpression and knockdown\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct binding plus functional gain/loss-of-function, single lab\",\n      \"pmids\": [\"19564890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NANOG directly binds the proximal promoter of Gata6 and represses its expression; NANOG overexpression reduces heterogeneity and Gata6-high cell frequency in mouse ES cells.\",\n      \"method\": \"ChIP at Gata6 proximal promoter, NANOG overexpression with quantitative marker analysis in mouse ES cells\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional overexpression readout, single lab\",\n      \"pmids\": [\"17615266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Human NANOG contains a C-terminal prion-like domain that phase-transitions to gel-like condensates; full-length NANOG forms higher-order oligomers at low nanomolar concentrations. NANOG oligomerization is essential for bridging DNA elements in vitro, and prion-like domain assembly is required for specific DNA recognition and distant chromatin interactions in cells, providing a physical basis for chromatin reorganization and dose-sensitive activation of ground-state pluripotency.\",\n      \"method\": \"Single-molecule FRET, fluorescence cross-correlation spectroscopy, phase-transition assays, ChIP-seq, Hi-C 3.0 in cells, prion-like domain mutants\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution (smFRET, FCS, in vitro DNA bridging) combined with in-cell ChIP-seq and Hi-C with domain mutants, multiple orthogonal Tier 1-2 methods in one study\",\n      \"pmids\": [\"35484250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In zebrafish embryos, Nanog clusters prior to transcription body formation; Nanog clustering is required for subsequent Sox19b clustering and transcription initiation. Both the DNA-binding domain and an intrinsically disordered region of Nanog are required to organize transcription bodies.\",\n      \"method\": \"Live imaging of fluorescent reporters in zebrafish embryos, mutant analysis of Nanog domains (DNA-binding domain and IDR), transcription body formation assay\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live-cell imaging with genetic domain mutants in zebrafish, single lab\",\n      \"pmids\": [\"36476751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Zebrafish Nanog and Pou5f3 bind to high nucleosome affinity regions (HNARs) at zygotic genome activation; in the first step, Pou5f3 and Nanog destabilize nucleosomes at HNAR centers before ZGA; in the second step, Nanog, Pou5f3, and SoxB1 synergistically maintain open chromatin—Nanog binds to HNAR center while Pou5f3 stabilizes flanks.\",\n      \"method\": \"MNase-seq in wild-type and maternal-zygotic pou5f3 and nanog mutant zebrafish embryos, computational nucleosome occupancy modeling\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MNase-seq with genetic mutants in zebrafish, single lab\",\n      \"pmids\": [\"30674556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Medaka Nanog (Ol-Nanog) is expressed in PGCs and directly regulates Cxcr4b transcription by binding its promoter; Nanog depletion causes aberrant PGC migration and loss of Cxcr4b expression; simultaneous overexpression of Cxcr4b rescues the migration defect caused by Nanog depletion.\",\n      \"method\": \"ChIP (Ol-Nanog binding to Cxcr4b promoter), morpholino knockdown of Ol-Nanog, Cxcr4b mRNA rescue experiment in medaka\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirming direct binding plus genetic rescue experiment, multiple orthogonal methods single lab\",\n      \"pmids\": [\"20578184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In zebrafish maternal-zygotic nanog mutants, YSL formation and epiboly fail; Nanog is required for yolk microtubule organization, miR-430-mediated maternal mRNA degradation, and actin structure of the yolk syncytial layer. Cell death in MZnanog embryos is cell-autonomous. Nanog regulates spatial expression of ventral-specifying genes (bmp2b, vox, vent), neural factor her3, and degradation of maternal eomesa mRNA.\",\n      \"method\": \"Maternal-zygotic nanog mutant zebrafish analysis, chimera rescue experiments, live imaging, in situ hybridization, actin and microtubule staining\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cellular readouts in genetic null mutants with chimeric rescue, single lab\",\n      \"pmids\": [\"29180568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NANOG directly occupies the p27KIP1 (CDKN1B) promoter and represses its transcription; Nanog transduction into primary fibroblasts suppresses senescence-associated β-galactosidase activity and downregulates p27KIP1, correlating with enhanced proliferation.\",\n      \"method\": \"ChIP confirming Nanog binding at p27KIP1 gene; cell-permeant Nanog-TAT protein transduction; proliferation and senescence assays in NIH 3T3 and primary fibroblasts\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for direct binding plus functional protein transduction readout, single lab\",\n      \"pmids\": [\"26795560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DPPA5 directly interacts with NANOG protein in human PSCs, stabilizes NANOG via a post-transcriptional mechanism, and enhances NANOG function; DPPA5 overexpression increases NANOG protein levels without affecting mRNA, and DPPA5 depletion reduces NANOG.\",\n      \"method\": \"Co-immunoprecipitation, protein stability assay, quantitative RT-PCR (confirming post-transcriptional effect), overexpression/knockdown in human PSCs\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus protein stability assay plus mRNA vs protein dissociation, single lab\",\n      \"pmids\": [\"26661329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SUMOylation of Oct4 enhances NANOG expression, while SUMOylation of Sox2 inhibits NANOG expression. Depletion of Sumo1 or its conjugating enzyme Ubc9 increases Nanog expression; high SUMOylation reduces it. SUMOylation of Oct4 by Pias2 or Sox2 by Pias3 impairs the Oct4–Sox2 interaction.\",\n      \"method\": \"SUMOylation assays, Sumo1/Ubc9 knockdown, Pias2/Pias3 overexpression, Co-IP for Oct4-Sox2 interaction, NANOG expression readout in ES cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical SUMOylation assays plus Co-IP plus functional gene expression readout, single lab\",\n      \"pmids\": [\"22745796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NANOG directly binds the upstream region of ICAM1 in prostate cancer cells; as NANOG binding increases, p300 binding to this region is diminished, resulting in decreased ICAM1 expression, enabling cancer cells to evade NK cell attack.\",\n      \"method\": \"ChIP-seq (NANOG and p300), RNAseq, generation of NANOG-overexpressing/knockout transformants, NK cell cytotoxicity assays, xenograft in SCID mice\",\n      \"journal\": \"Journal of experimental & clinical cancer research : CR\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq for NANOG and p300 co-occupancy plus functional NK resistance assay, single lab\",\n      \"pmids\": [\"31619256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GATA6 and NANOG co-bind at the vast majority of epiblast and primitive endoderm enhancers, including in blastocysts. Upon GATA6 induction, co-bound state resolves by NANOG eviction and repression of epiblast TFs, with rapid chromatin remodeling and enhancer-promoter contact changes establishing primitive endoderm lineage.\",\n      \"method\": \"ChIP-seq for GATA6 and NANOG in ES cells and blastocysts, GATA6 induction system, chromatin accessibility assays, Hi-C/enhancer-promoter contact mapping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq replicated in two systems (ES cells and blastocysts), chromatin dynamics with Hi-C, multiple orthogonal methods\",\n      \"pmids\": [\"35871075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In bovine embryos, OCT4 is required for NANOG expression; OCT4 knockout blastocysts lack NANOG protein entirely in the ICM, while OCT4 is not required to suppress CDX2 in the ICM (contrasting with mouse).\",\n      \"method\": \"CRISPR-Cas9 OCT4 knockout in bovine fibroblasts, SCNT embryo production, immunofluorescence for NANOG, GATA6, CDX2 in blastocysts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR/KO with direct immunofluorescence protein readout in bovine blastocysts, single lab with rigorous controls\",\n      \"pmids\": [\"29483258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Esrrb, a positively regulated direct NANOG target in ES cells, can functionally replace Nanog in PGC development in vivo; knockin of Esrrb at the Nanog locus restores PGC numbers to wild-type and yields fertile adults.\",\n      \"method\": \"Germline-specific Nanog deletion, PGCLC differentiation assay with Nanog-null ES cells, Esrrb knockin to Nanog locus, fertility assessment\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis by knockin rescue in two contexts (in vitro PGCLC and in vivo germline), replicated outcomes\",\n      \"pmids\": [\"29320730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In mouse ES cells, Nanog-dependent feedback loops maintain ES cell population heterogeneity and fate decisions; early molecular changes after Nanog loss are stochastic and reversible, but prolonged Nanog absence consolidates commitment. Exogenous regulation of Nanog-dependent feedback control produces a more homogeneous ES cell population.\",\n      \"method\": \"Genetic complementation strategy, high-throughput single-cell transcriptional profiling, mathematical modeling, exogenous Nanog regulation\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-cell profiling with genetic manipulation and mathematical modeling, single lab\",\n      \"pmids\": [\"23103910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"YBX1 and ILF3 RNA-binding proteins interact with Nanog mRNA in mouse ES cells; knockdown of YBX1 or ILF3 reduces Nanog and other pluripotency gene expression and leads to mesoderm marker upregulation.\",\n      \"method\": \"Affinity purification of Nanog-interacting RBPs, RNA immunoprecipitation (RIP), immunofluorescence, FISH, MS2-BioTRAP, RNAi knockdown with gene expression readout\",\n      \"journal\": \"Cell biology international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP and MS2-BioTRAP confirming RNA interaction plus functional KD, single lab\",\n      \"pmids\": [\"26289635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TRRAP directly binds NANOG (via TRRAP amino acids 1898–2400) and stabilizes NANOG protein by interfering with FBXW8-mediated ubiquitination; TRRAP depletion reduces cancer stem cell traits and tumor growth, which can be rescued by NANOG overexpression.\",\n      \"method\": \"Co-IP with TRRAP deletion mutants, ubiquitination assay, TRRAP knockdown/overexpression with NANOG protein stability readout, xenograft rescue experiment\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping, ubiquitination assay, functional rescue, single lab\",\n      \"pmids\": [\"37047234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nanog ChIP analysis showed physical binding to Cdx2 and Klf4 promoters in intestinal epithelium of Nanog-inducible mice, resulting in their downregulation, increased crypt cell proliferation, and intestinal hyperplasia without tumor formation.\",\n      \"method\": \"Tet-On inducible Nanog mouse model, ChIP at Cdx2 and Klf4 promoters, histological analysis of intestinal tissue\",\n      \"journal\": \"Stem cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP in vivo confirming direct promoter binding plus in vivo phenotypic readout, single lab\",\n      \"pmids\": [\"25173648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NANOG and LIN28 drive reprogramming by activating LIN41 expression (a Let-7 miRNA target) and activating canonical WNT/β-CATENIN signaling; LIN41 can replace LIN28 synergizing with NANOG; dominant-negative LIN41 mutation blocks NANOG/LIN28-enhanced reprogramming.\",\n      \"method\": \"Reprogramming efficiency assays, pathway inhibitor treatments, dominant-negative LIN41 mutant, overexpression of LIN41 in OSKM context, measurement of WNT activation\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional epistasis via dominant-negative mutant and pathway inhibition, single lab\",\n      \"pmids\": [\"31806618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In mouse ES cells, Satb1 and Satb2 both bind the Nanog locus in vivo; Satb1-deficient ES cells show increased Nanog expression and higher proportion of Nanog-high cells; Satb1 and Satb2 have antagonistic effects on Nanog expression and ES cell differentiation capacity.\",\n      \"method\": \"ChIP (Satb1 and Satb2 binding at Nanog locus), Satb1/Satb2 knockout ES cells, Satb2 overexpression, differentiation assays, cell fusion reprogramming assay\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at Nanog locus plus genetic KO readout, single lab\",\n      \"pmids\": [\"19933152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BRD4 associates with BRG1 at Nanog regulatory regions in mouse ES cells to regulate Nanog expression; inhibition of BRD4 (chemically, siRNA, or dominant-negative) suppresses Nanog expression and abolishes ES cell self-renewal.\",\n      \"method\": \"ChIP (BRD4 and BRG1 at Nanog locus), BRD4 chemical inhibitor, siRNA knockdown, dominant-negative BRD4, Nanog expression and self-renewal readout\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus three independent BRD4 inhibition strategies, single lab\",\n      \"pmids\": [\"25146928\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CDX2 induction in mouse ES cells causes time-dependent increase in CDX2 binding and decrease in OCT4 binding at Nanog regulatory elements, loss of H3K9/14 acetylation and p300/HDAC1 binding, increased histone H3 occupancy, loss of chromatin accessibility, and only later DNA methylation at Nanog regulatory elements—demonstrating sequential epigenetic silencing of Nanog.\",\n      \"method\": \"Cdx2-inducible ES cell line, ChIP time course (CDX2, OCT4, RNAPII, H3K9/14ac, p300, HDAC1, total H3), chromatin accessibility assay, bisulfite sequencing\",\n      \"journal\": \"Stem cells and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — detailed ChIP time course with multiple histone marks and TFs at Nanog locus, single lab\",\n      \"pmids\": [\"24059348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NANOG triggers epiblast specification by ensuring coordinated expression of pluripotency markers; in Nanog/Gata6 double KO embryos, coordination of pluripotency markers fails, while individual marker expression remains variable in ICM progenitors.\",\n      \"method\": \"Nanog/Gata6 double knockout mouse embryo analysis, single-cell transcriptomics, immunofluorescence, analysis of human embryos\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with single-cell transcriptomics and cross-species validation, single lab\",\n      \"pmids\": [\"35729116\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NANOG is a divergent homeodomain transcription factor that homodimerizes via its C-terminal domain—with dimerization required for interaction with pluripotency network partners and for LIF-independent self-renewal—forms higher-order prion-like oligomers through its C-terminal disordered domain to bridge distant chromatin elements and organize transcription bodies, directly occupies target gene promoters and enhancers (including Gata6, Cdx2, Cxcr4b, p27KIP1, Bmi1, ICAM1) to activate or repress transcription, interacts physically with TET1/TET2 to increase 5-hydroxymethylcytosine at pluripotency loci, with SALL4 and Med12 to co-regulate ES cell gene networks, and is itself subject to multilayered post-translational control: phosphorylation by ERK1/ERK2 and PKCε regulates its stability (via FBXW8-mediated K48-linked ubiquitination and proteasomal degradation), AMPK-BRAF-mediated phosphorylation at Ser68 modulates its recognition by the E3 ligase SPOP, and USP21 deubiquitylase and DPPA5/TRRAP stabilize NANOG protein, collectively controlling pluripotency maintenance, somatic reprogramming efficiency, germline development, and cancer stem cell traits.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NANOG is a divergent homeodomain transcription factor that operates at the core of the pluripotency network, directly occupying target promoters and enhancers to activate or repress lineage and self-renewal programs and to coordinate cell-fate decisions in the early embryo and germline [#23, #34, #25]. It homodimerizes through its C-terminal domain rather than the homeodomain, and this dimerization is required both for assembly with pluripotency network partners and for LIF-independent self-renewal [#1]; its C-terminal prion-like/intrinsically disordered region drives higher-order oligomerization and phase transition that bridges distant DNA elements, enables specific DNA recognition, and organizes transcription bodies for dose-sensitive activation of ground-state pluripotency [#14, #15]. NANOG nucleates an activating circuitry with SALL4 and the Mediator subunit Med12 to co-regulate ES cell gene networks [#2, #10], and recruits TET1/TET2 to co-bound loci to deposit 5-hydroxymethylcytosine and enhance reprogramming [#3]. As a sequence-specific regulator it represses Gata6, Cdx2 and p27KIP1 and activates Esrrb and other targets, thereby suppressing endoderm/trophectoderm fate, controlling proliferation and senescence, and—through co-binding and resolution with GATA6—governing the epiblast versus primitive-endoderm decision [#13, #12, #19, #23]. In germ cells NANOG is specifically required for primordial germ cell maturation, a function that the direct target Esrrb can substitute for in vivo [#0, #25]. NANOG abundance is set by extensive post-translational control: ERK1/ERK2 and CDK1/CyclinA2 phosphorylate it, with ERK-driven phosphorylation triggering FBXW8-mediated K48-linked ubiquitination and degradation, while PKCε phosphorylation at T200/T280 stabilizes it and is required for dimerization, DNA binding and p300 recruitment to activate Bmi1 [#4, #9, #8]. The E3 ligase SPOP targets a NANOG degron for degradation, an event blocked by AMPK-BRAF phosphorylation at Ser68 and by Pin1, whereas USP21 deubiquitylation and the DPPA5 and TRRAP stabilizers oppose turnover—a control axis that drives prostate cancer and cancer-stem-cell traits including immune evasion via ICAM1 repression [#5, #6, #7, #20, #28, #22]. Beyond pluripotency, NANOG governs nucleosome remodeling at zygotic genome activation and yolk syncytial layer/epiboly programs in fish embryos [#16, #18].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Established that NANOG does not act alone but forms a positive autoregulatory circuit with a defined protein partner, framing it as a network hub rather than a solitary factor.\",\n      \"evidence\": \"Affinity-MS, reciprocal Co-IP, GST pulldown, ChIP co-occupancy and reporter assays in mouse ES cells defining the NANOG-SALL4 circuit\",\n      \"pmids\": [\"16840789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which NANOG domain mediates SALL4 binding\", \"Did not establish genome-wide scope of co-regulated targets\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the apparent paradox of NANOG's role by showing it is dispensable for somatic pluripotency maintenance yet specifically essential for germ-cell maturation, defining a developmental-stage-specific requirement.\",\n      \"evidence\": \"Nanog knockout chimera analysis with allelic germline rescue in mouse; ChIP at the Gata6 promoter in a separate study\",\n      \"pmids\": [\"18097409\", \"17615266\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the germline target genes downstream of NANOG\", \"Mechanism of stage specificity left open\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified the structural basis of NANOG function by mapping C-terminal homodimerization and showing it is required for partner binding and self-renewal, and connected NANOG to the Mediator complex.\",\n      \"evidence\": \"Domain-deletion mapping with monomer/dimer constructs and self-renewal rescue; Co-IP/ChIP linking Med12 to NANOG targets in mouse ES cells\",\n      \"pmids\": [\"18436640\", \"19036726\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not show the dimer structure at atomic resolution\", \"Did not distinguish direct versus Mediator-bridged partner interactions\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined the transcriptional inputs and reciprocal-repression logic governing NANOG, situating it in the OCT4/SOX2/KLF4/PBX1 activation circuit and the NANOG-CDX2 mutual antagonism that enforces lineage choice.\",\n      \"evidence\": \"Promoter reporter, ChIP, EMSA and motif mutagenesis in human ES cells; ChIP and gain/loss-of-function for NANOG-CDX2 mutual repression; ChIP at the Nanog locus for Satb1/Satb2\",\n      \"pmids\": [\"19522013\", \"19564890\", \"19933152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cross-species generality of these regulatory inputs not addressed\", \"Did not quantify relative contribution of each upstream factor\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected NANOG transcriptional output directly to germ-cell behavior by identifying a migration-guidance target gene whose re-expression rescues the loss-of-function phenotype.\",\n      \"evidence\": \"ChIP, morpholino knockdown and Cxcr4b mRNA rescue in medaka PGCs\",\n      \"pmids\": [\"20578184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether vertebrate orthologs use the same NANOG-Cxcr4b axis untested\", \"Did not address other migration regulators\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed two distinct mechanistic layers: NANOG recruits the DNA-demethylation machinery to remodel the epigenome, and PKCε phosphorylation stabilizes NANOG and licenses its DNA-binding/coactivator functions in tumorigenesis.\",\n      \"evidence\": \"Affinity-MS/Co-IP/ChIP-seq with TET1 catalytic mutant and 5hmC quantification; PKCε kinase assay with phospho-mutants, ChIP, reporter and xenograft assays\",\n      \"pmids\": [\"23395962\", \"23708658\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide rules for NANOG-directed TET recruitment incomplete\", \"Functional weight of T200/T280 phosphorylation in normal pluripotency unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that NANOG abundance is gated by kinase-coupled ubiquitination, with ERK/CDK1 phosphorylation feeding FBXW8-mediated proteasomal degradation that drives differentiation, and that population-level NANOG feedback governs cell-fate heterogeneity.\",\n      \"evidence\": \"In vitro kinase, Co-IP, ubiquitination and MEK-inhibitor assays in mouse ES cells; endogenous phosphosite MS with MAKS kinase-specificity mapping; single-cell profiling with genetic complementation; ChIP and BRD4/BRG1 inhibition at the Nanog locus; in vivo Cdx2/Klf4 promoter ChIP\",\n      \"pmids\": [\"24793005\", \"24678451\", \"23103910\", \"25146928\", \"25173648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hierarchy among the multiple phosphosites in vivo not resolved\", \"Did not reconcile FBXW8 with later-identified SPOP-dependent degradation\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified a post-transcriptional stabilizer of NANOG protein, expanding control of NANOG levels beyond transcription and kinase signaling.\",\n      \"evidence\": \"Co-IP, protein-stability and mRNA-versus-protein dissociation assays with DPPA5 in human PSCs\",\n      \"pmids\": [\"26661329\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab without reciprocal in vivo validation\", \"Did not define the DPPA5-NANOG interaction interface or the ligase it antagonizes\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed that deubiquitylation actively opposes NANOG turnover and that NANOG transcriptionally represses a cell-cycle/senescence brake, linking its stability and target repression to proliferation control.\",\n      \"evidence\": \"Co-IP, domain mapping and K48 deubiquitylation assay with USP21 in mouse ES cells; ChIP at p27KIP1 with Nanog-TAT transduction and senescence assays; RIP/MS2-BioTRAP defining Nanog mRNA-binding proteins\",\n      \"pmids\": [\"29263902\", \"26795560\", \"26289635\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether USP21 and DPPA5/FBXW8 act on overlapping pools of NANOG unknown\", \"Direct versus indirect p27KIP1 repression in vivo not fully resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined a clinically relevant degron-and-phosphorylation switch (SPOP/AMPK-BRAF-Ser68/Pin1) controlling NANOG stability in cancer, and refined the embryonic transcriptional hierarchy and germline target logic across species.\",\n      \"evidence\": \"Co-IP/ubiquitination/degron-mutant and Pin1 assays plus tumor models for SPOP and Ser68 (two independent labs); Esrrb knockin rescue of Nanog-null PGCs; CRISPR OCT4 knockout in bovine embryos; MZnanog zebrafish mutant analysis\",\n      \"pmids\": [\"30595538\", \"30595535\", \"29320730\", \"29483258\", \"29180568\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between SPOP and FBXW8 degradation pathways not directly compared\", \"Species differences in the OCT4-NANOG-CDX2 hierarchy mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked NANOG to nucleosome destabilization at zygotic genome activation and to cancer immune evasion, broadening its mechanistic reach from pioneer-like chromatin opening to enhancer repression that lowers ICAM1 and NK susceptibility.\",\n      \"evidence\": \"MNase-seq in maternal-zygotic nanog/pou5f3 zebrafish mutants; ChIP-seq/RNA-seq with NANOG knockout and NK cytotoxicity/xenograft assays for ICAM1; reprogramming epistasis with LIN28/LIN41/WNT\",\n      \"pmids\": [\"30674556\", \"31619256\", \"31806618\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether NANOG acts as a bona fide pioneer factor or cooperates with co-factors at HNARs unresolved\", \"Generality of ICAM1 repression beyond prostate cancer untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided the biophysical basis for NANOG action by showing prion-like-domain-driven oligomerization and phase transition mediate DNA bridging, transcription-body organization, and dose-sensitive ground-state pluripotency, and detailed the GATA6 co-binding/eviction mechanism of lineage segregation.\",\n      \"evidence\": \"smFRET/FCS/phase-transition reconstitution with ChIP-seq and Hi-C 3.0 and prion-like-domain mutants; live imaging of Nanog/Sox19b clustering in zebrafish; GATA6/NANOG ChIP-seq with Hi-C in ES cells and blastocysts; Nanog/Gata6 double-KO single-cell embryo analysis\",\n      \"pmids\": [\"35484250\", \"36476751\", \"35871075\", \"35729116\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo dynamics and regulation of NANOG condensates incompletely defined\", \"Mechanism coupling oligomerization state to target selectivity not fully resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Added a further stabilizing cofactor, showing TRRAP protects NANOG from FBXW8-mediated ubiquitination to sustain cancer-stem-cell traits, reinforcing degradation control as a therapeutic node.\",\n      \"evidence\": \"Co-IP with TRRAP deletion mutants, ubiquitination assay and xenograft rescue by NANOG overexpression\",\n      \"pmids\": [\"37047234\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; reciprocal in vivo validation limited\", \"Whether TRRAP acts through its known complexes or independently to block FBXW8 unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple, partly redundant degradation (FBXW8, SPOP) and stabilization (USP21, DPPA5, TRRAP, Pin1) inputs are integrated with phosphorylation and condensate state to set NANOG dosage in a given cell context remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model linking NANOG abundance, oligomerization and target selection\", \"Relative dominance of competing E3 ligases and stabilizers across cell types unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 12, 13, 19, 22, 23, 29]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [8, 14, 16]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 14, 23]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [14, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 13, 23, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 23, 25, 34]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 5, 7, 28]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [3, 16, 33]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 6, 8, 22]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SALL4\", \"TET1\", \"TET2\", \"MED12\", \"SPOP\", \"USP21\", \"FBXW8\", \"DPPA5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}